AAAAAA

   
Results: 1-10 |
Results: 10
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations
Authors: Sessa, A Battini, G Meroni, M Daidone, G Carnera, I Brambilla, PL Vigano, G Giordano, F Pallotti, F Tarelli, LT Calabresi, L Rolleri, M Bertolini, S
Citation: A. Sessa et al., Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations, NEPHRON, 88(3), 2001, pp. 268-272
Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL
Authors: Calabresi, L Tedeschi, G Treu, C Ronchi, S Galbiati, D Airoldi, S Sirtori, CR Marcel, Y Franceschini, G
Citation: L. Calabresi et al., Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL, J LIPID RES, 42(6), 2001, pp. 935-942
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease
Authors: Bertolini, S Pisciotta, L Seri, M Cusano, R Cantafora, A Calabresi, L Franceschini, G Ravazzolo, R Calandra, S
Citation: S. Bertolini et al., A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease, ATHEROSCLER, 154(3), 2001, pp. 599-605
Cardiovascular status of carriers of the apolipoprotein A-I-Milano mutant - The Limone sul Garda study
Authors: Sirtori, CR Calabresi, L Franceschini, G Baldassarre, D Amato, M Johansson, J Salvetti, M Monteduro, C Zulli, R Muiesan, ML Agabiti-Rosei, E
Citation: Cr. Sirtori et al., Cardiovascular status of carriers of the apolipoprotein A-I-Milano mutant - The Limone sul Garda study, CIRCULATION, 103(15), 2001, pp. 1949-1954
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
Authors: Sirtori, CR Calabresi, L Ferrara, S Pazzucconi, F Bondioli, A Baldassarre, D Birreci, A Koverech, A
Citation: Cr. Sirtori et al., L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a), NUTR MET CA, 10(5), 2000, pp. 247-251
Cardiovascular risk changes after lipid lowering medications: are they predictable?
Authors: Sirtori, CR Calabresi, L Marchioli, R Rubins, HB
Citation: Cr. Sirtori et al., Cardiovascular risk changes after lipid lowering medications: are they predictable?, ATHEROSCLER, 152(1), 2000, pp. 1-8
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
Authors: Calabresi, L Donati, D Pazzucconi, F Sirtori, CR Franceschini, G
Citation: L. Calabresi et al., Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses, ATHEROSCLER, 148(2), 2000, pp. 387-396
Increased cholesterol efflux potential of sera from ApoA-I-Milano carriersand transgenic mice
Authors: Franceschini, G Calabresi, L Chiesa, G Parolini, C Sirtori, CR Canavesi, M Bernini, F
Citation: G. Franceschini et al., Increased cholesterol efflux potential of sera from ApoA-I-Milano carriersand transgenic mice, ART THROM V, 19(5), 1999, pp. 1257-1262
Recombinant apolipoproteins for the treatment of vascular diseases
Authors: Sirtori, CR Calabresi, L Franceschini, G
Citation: Cr. Sirtori et al., Recombinant apolipoproteins for the treatment of vascular diseases, ATHEROSCLER, 142(1), 1999, pp. 29-40
Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-I-Milano dimer
Authors: Calabresi, L Canavesi, M Bernini, F Franceschini, G
Citation: L. Calabresi et al., Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-I-Milano dimer, BIOCHEM, 38(49), 1999, pp. 16307-16314
Risultati: 1-10 |